Pharmacology News

The balance of risks and benefits when it comes to treating musculoskeletal pain with opioids in the ED setting remains unclear, according to researchers.

The U.S. Preventive Services Task Force in August published a statement regarding the initiation of statin therapy for the primary prevention of atherosclerotic CVD.

There are drug-drug interactions between the COVID-19 treatment ritonavir/nirmatrelvir and various classes of commonly used CV medications, according to a review paper.

HHS Secretary Xavier Becerra has amended the Public Readiness and Emergency Preparedness Act declaration, expanding the pool of providers authorized to administer vaccines against smallpox and monkeypox.

HHS has released two new reports that it said not only “illustrate the urgency of addressing skyrocketing prescription drug costs in America,” but also highlight the potential positive impact of the Inflation Reduction Act.

An expert consensus decision pathway recently issued by the American College of Cardiology addresses lipid-lowering therapies that were developed after the publication of the ACC/American Heart Association cholesterol guidelines in 2018.

Despite being deauthorized by the FDA on Jan. 24, 2022, due to omicron variant inefficiency, two monoclonal antibody treatments were administered more than 158,000 times to patients with COVID-19, according to a study in JAMA Network Open.

While statin therapy may cause a small excess of mostly mild muscle pain, most muscle symptoms reported in statin trials were not caused by the drug, according to a meta-analysis presented at the European Society of Cardiology Congress.

Patients taking antihypertensive medication in the evening experienced no difference in MI, stroke or CV death occurrence compared with patients taking them in the morning, a speaker reported.

The U.S. Preventive Services Task Force’s new recommendation statement on the use of statin therapy for primary prevention in adults aged 40 to 75 years with no history of CVD is similar to its 2016 recommendations.